| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |